Pfizer Inc. said Wednesday it asked European Union regulators to approve its drug candidate axitinib as a treatment for kidney cancer.
Popular Posts:
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- FDA delays decision on lupus drug Benlysta